{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:59:05Z","timestamp":1795089545791,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2119\/molmed.2010.00008","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T19:54:15Z","timestamp":1289418855000},"page":"498-504","source":"Crossref","is-referenced-by-count":34,"title":["Early Increase of Plasma Homocysteine in Sepsis Patients with Poor Outcome"],"prefix":"10.1186","volume":"16","author":[{"given":"Martin","family":"Ploder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Spittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neurauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,1]]},"reference":[{"key":"1611498_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274:1049\u201357.","journal-title":"J. Am. Med. Assoc."},{"key":"1611498_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J. (1998) Homocysteine and atherothrombosis. N. Engl. J. Med. 338:1042\u201350.","journal-title":"N. Engl. J. Med."},{"key":"1611498_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"GJ Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom JW. (1999) Homocysteine and vascular disease. Lancet 354:407\u201313.","journal-title":"Lancet"},{"key":"1611498_CR4","doi-asserted-by":"publisher","first-page":"1563S","DOI":"10.1093\/ajcn\/86.5.1563S","volume":"86","author":"KS McCully","year":"2007","unstructured":"McCully KS. (2007) Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 86:1563S\u20138S.","journal-title":"Am. J. Clin. Nutr."},{"key":"1611498_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1373\/clinchem.2007.085480","volume":"53","author":"PM Ueland","year":"2007","unstructured":"Ueland PM, Clarke R. (2007) Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power. Clin. Chem. 53:807\u20139.","journal-title":"Clin. Chem."},{"key":"1611498_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2249.2003.02251.x","volume":"134","author":"K Schroecksnadel","year":"2003","unstructured":"Schroecksnadel K, Frick B, Wirleitner B, Schennach H, Fuchs D. (2003) Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Clin. Exp. Immunol. 134:53\u20136.","journal-title":"Clin. Exp. Immunol."},{"key":"1611498_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/01.wad.0000127443.23312.31","volume":"18","author":"K Schroecksnadel","year":"2004","unstructured":"Schroecksnadel K, Leblhuber F, Frick B, Wirleitner B, Fuchs D. (2004) Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels. Alzheimer Dis. Assoc. Disord. 18:129\u201333.","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"1611498_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cccn.2003.09.003","volume":"338","author":"K Schroecksnadel","year":"2003","unstructured":"Schroecksnadel K, et al. (2003) Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Clin. Chim. Acta 338:157\u201364.","journal-title":"Clin. Chim. Acta"},{"key":"1611498_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2796.2007.01810.x","volume":"262","author":"Bleie","year":"2007","unstructured":"Bleie \u00d8, et al. (2007) Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J. Intern. Med. 262:244\u201353.","journal-title":"J. Intern. Med."},{"key":"1611498_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/eurheartj\/ehi111","volume":"26","author":"P Avanzas","year":"2005","unstructured":"Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. (2005) Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur. Heart J. 26:457\u201363.","journal-title":"Eur. Heart J."},{"key":"1611498_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2008.01.009","volume":"201","author":"JC Kaski","year":"2008","unstructured":"Kaski JC, et al. (2008) Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis 201:176\u201383.","journal-title":"Atherosclerosis"},{"key":"1611498_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","volume":"47","author":"N Rifai","year":"2001","unstructured":"Rifai N, Ridker PM. (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 47:403\u201311.","journal-title":"Clin. Chem."},{"key":"1611498_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1084\/jem.160.1.310","volume":"160","author":"C Huber","year":"1984","unstructured":"Huber C, et al. (1984) Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:310\u20136.","journal-title":"J. Exp. Med."},{"key":"1611498_CR14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1189\/jlb.72.6.1148","volume":"72","author":"B Wirleitner","year":"2002","unstructured":"Wirleitner B, et al. (2002) Monocyte-derived dendritic cells release neopterin. J. Leukocyte Biol. 72:1148\u201353.","journal-title":"J. Leukocyte Biol."},{"key":"1611498_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr C, Widner B, Wirleitner B, Fuchs D. (2002) Neopterin as a marker for immune system activation. Curr. Drug Metabol. 3:175\u201387.","journal-title":"Curr. Drug Metabol."},{"key":"1611498_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/MCC.0b013e3280106806","volume":"12","author":"S Zedler","year":"2006","unstructured":"Zedler S, Faist E. (2006) The impact of endogenous triggers on trauma-associated inflammation. Curr. Opin. Crit. Care 12:595\u2013601.","journal-title":"Curr. Opin. Crit. Care"},{"key":"1611498_CR17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1515\/pteridines.2009.20.1.54","volume":"19","author":"M Ploder","year":"2009","unstructured":"Ploder M, et al. (2009) Accelerated tryptophan degradation in trauma and sepsis patients is related to pro-inflammatory response and to the diminished in vitro response of monocytes. Pteridines 19:54\u201361.","journal-title":"Pteridines"},{"key":"1611498_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/CS20080319","volume":"116","author":"M Ploder","year":"2009","unstructured":"Ploder M, et al. (2009). Tryptophan degradation in multiple trauma patients: survivors versus non-survivors. Clin. Sci. 116:593\u2013598.","journal-title":"Clin. Sci."},{"key":"1611498_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00003246-198708000-00009","volume":"15","author":"W Strohmaier","year":"1987","unstructured":"Strohmaier W, Redl H, Schlag G, Inthorn D. (1987) d-Erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit. Care Med. 15:757\u201360.","journal-title":"Crit. Care Med."},{"key":"1611498_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/01.shk.0000093541.78705.38","volume":"20","author":"T Hensler","year":"2003","unstructured":"Hensler T, et al. (2003) The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20:420\u20136.","journal-title":"Shock"},{"key":"1611498_CR21","first-page":"209","volume":"23","author":"K Pellegrin","year":"2005","unstructured":"Pellegrin K, et al. (2005) Enhanced enzymatic degradation of tryptophan by indoleamine (2,3)-dioxygenase contributes to the tryptophan deficient state seen after major trauma. Shock 23:209\u201315.","journal-title":"Shock"},{"key":"1611498_CR22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1378\/chest.101.6.1481","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481\u20133.","journal-title":"Chest"},{"key":"1611498_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0009-8981(03)00076-7","volume":"331","author":"B Frick","year":"2003","unstructured":"Frick B, et al. (2003) Rapid measurement of total plasma homocysteine by HPLC. Clin. Chim. Acta 331:19\u201323.","journal-title":"Clin. Chim. Acta"},{"key":"1611498_CR24","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7326\/0003-4819-131-5-199909070-00003","volume":"131","author":"J Selhub","year":"1999","unstructured":"Selhub J, et al. (1999) Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991\u20131994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann. Intern. Med. 131:331\u20139.","journal-title":"Ann. Intern. Med."},{"key":"1611498_CR25","first-page":"403","volume":"157","author":"WE Brandhof van den","year":"2001","unstructured":"van den Brandhof WE, Haks K, Schouten EG, Verhoef P. (2001) The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis 2001;157:403\u20139.","journal-title":"Atherosclerosis 2001"},{"key":"1611498_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1084\/jem.158.3.670","volume":"158","author":"CF Nathan","year":"1983","unstructured":"Nathan CF, Murray HW, Wiebe ME, Rubin BY. (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670\u201389.","journal-title":"J. Exp. Med."},{"key":"1611498_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1042\/bj1780795","volume":"178","author":"MJ Connor","year":"1979","unstructured":"Connor MJ, Pheasant AE, Blair JA. (1979) The identification of p-acetaminobenzoate as a folate degradation product in rat urine. Biochem. J. 178:795\u20137.","journal-title":"Biochem. J."},{"key":"1611498_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1515\/CCLM.2001.113","volume":"39","author":"D Fuchs","year":"2001","unstructured":"Fuchs D, et al. (2001) Is hyperhomocysteinemia due to oxidative depletion of folate rather than insufficient dietary intake? Clin. Chem. Lab. Med. 39:691\u20134.","journal-title":"Clin. Chem. Lab. Med."},{"key":"1611498_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1046\/j.1365-2249.1999.00910.x","volume":"116","author":"G Weiss","year":"1999","unstructured":"Weiss G, et al. (1999) Modulation of neopterin formation and tryptophan degradation by Th1-and Th2-derived cytokines in human monocytic cells. Clin. Exp. Immunol. 116:435\u201340.","journal-title":"Clin. Exp. Immunol."},{"key":"1611498_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1515\/CCLM.2003.221","volume":"41","author":"K Schroecksnadel","year":"2003","unstructured":"Schroecksnadel K, et al. (2003) Hyperhomocysteinemia and immune activation. Clin. Chem. Lab. Med. 41:1438\u201343.","journal-title":"Clin. Chem. Lab. Med."},{"key":"1611498_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.atherosclerosis.2008.04.047","volume":"202","author":"C Murr","year":"2009","unstructured":"Murr C, et al. (2009 Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 202:543\u20139.","journal-title":"Atherosclerosis"},{"key":"1611498_CR32","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1515\/CCLM.2007.264","volume":"45","author":"C Murr","year":"2007","unstructured":"Murr C, et al. (2007) Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders. Clin. Chem. Lab. Med. 45:1224\u20138.","journal-title":"Clin. Chem. Lab. Med."},{"key":"1611498_CR33","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00702-006-0539-x","volume":"113","author":"B Frick","year":"2006","unstructured":"Frick B, Gruber B, Schroecksnadel K, Leblhuber F, Fuchs D. (2006) Homocysteine but not neopterin declines in demented patients on B vitamins. J. Neural. Transm. 113:1815\u20139.","journal-title":"J. Neural. Transm."},{"key":"1611498_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/IJTR.S2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ. (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int. J. Tryptophan Res. 2:1\u201319.","journal-title":"Int. J. Tryptophan Res."},{"key":"1611498_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1515\/CCLM.2008.121","volume":"46","author":"K Schroecksnadel","year":"2008","unstructured":"Schroecksnadel K, et al. (2008) Association between plasma thiols and immune activation marker neopterin in stable coronary heart disease. Clin. Chem. Lab. Med. 46:648\u201354.","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2010.00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2010.00008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:04:16Z","timestamp":1685855056000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2010.00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":35,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1611498"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2010.00008","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}